These findings suggest a critical interaction between anti-MDA5 antibodies and the overexpressed MDA5 protein, which may act as a pathogenic driver in the progression of anti-MDA5+ DM-related ILD (63). This evidence concerns the gene IFIH1 and dermatomyositis.